FY27 F18 Florebetapir
- Response deadline
- Sep 29, 2026 Closed
- Date posted
- Sep 23, 2026
- Source
- Open notice
Description
NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT TO PETNET SOLUTIONS, INC., located at 810 Innovation Dr. Knoxville, TN 37932 for F18 Florbetapir for the Orlando Healthcare System, 13800 Veterans Way, Orlando, FL 32827. This procurement is being conducted in accordance with 41 USC 3304(a)(1) as implemented by FAR 6.302-1. The North American Industry Classification System code for this procurement is 325412 and the small business administrative size standard is 1,300 Employees. The current Federal Acquisition Circular and the Revolutionary Federal Acquisition Regulation Overhaul dated 07/01/2026. If vendors believe they have the technical capability to meet this specific need, submit a complete technical package, which provides clear and convincing evidence that they can meet the Government s requirement. Submit your response to this notice no later than 09/29/2026, 1:00 PM Eastern Standard Time to Contracting Officer, Benjamin Amato, benjamin.amato@va.gov. Any responses received will be considered for the purposes of validating the requirement as sole source. The Government will not pay for information submitted. This will be the only notice of the Government s intent to solicit, and award to one source to satisfy this requirement.
Classifications
Documents (2)
- 36C24826Q1256.docx.docx16 KBNot yet available
- attachmentNot yet available
Contacts
- Contracting Officerbenjamin.amato@va.gov407-646-4005
Similar contracts
- Sirturo (Bedaquiline) tablets for the NIH (Notice of Intent to sole source)MarylandDue Nov 11, 2026
- Request for Information (RFI) - Specialty Pharmacy List - Pharmaceutical Prime Vendor (PPV) 2028Due Nov 16, 2026
- SOURCES SOUGHT Charleston CMOP CARBOXYMETHYLCELLULOSE NA 0.25% OPH SOLN 15MLSouth CarolinaDue Nov 12, 2026
- General Radioisotopes (Diagnostic & Therapeutic)UtahDue Nov 12, 2026
- Epinephrine InjectorDue Nov 30, 2026
- Sources Sought VISN2 DOWNSTATE GENERAL RADIOPHARMACEUTICALSDue Nov 17, 2026